HeadlinesBriefing favicon HeadlinesBriefing

Sector Investment 24 Hours

×
1 articles summarized · Last updated: LATEST

Last updated: May 20, 2026, 5:36 PM ET

Sector Investment

Eir Partners acquired controlling interest in Quartz Bio, a Frederick‑based life‑science tech firm, expanding its portfolio in gene‑editing and CRISPR platforms, a move that could unlock new therapeutic pipelines valued at up to $1.5bn by 2027.